1. Nicotinamide is an inhibitor of SIRT1 in vitro, but can be a stimulator in cells.
    Eun Seong Hwang et al, 2017, Cell Mol Life Sci CrossRef
  2. Renal damage in the metabolic syndrome (MetSx): Disorders implicated
    Trujillo Joyce et al, 2017, European Journal of Pharmacology CrossRef
  3. Resistin facilitates VEGF-C-associated lymphangiogenesis by inhibiting miR-186 in human chondrosarcoma cells.
    Chen-Ming Su et al, 2018, Biochem Pharmacol CrossRef
  4. The Role of Apelin in Cardiovascular Diseases, Obesity and Cancer.
    Marta B Wysocka et al, 2018, Front Physiol CrossRef
  5. Leptin and its receptor: can they help to differentiate chromophobe renal cell carcinoma from renal oncocytoma?
    K.L. Ng et al, 2018, Pathology CrossRef
  6. Resistin facilitates VEGF-A-dependent angiogenesis by inhibiting miR-16-5p in human chondrosarcoma cells
    Shiou-Sheng Chen et al, 2019, Cell Death Dis CrossRef
  7. Apelin and apelin receptor expression in renal cell carcinoma
    Yuri Tolkach et al, 2019, Br J Cancer CrossRef
  8. Immunostaining characteristics of irisin in benign and malignant renal cancers
    T. Kuloğlu et al, 2019, Biotechnic & Histochemistry CrossRef
  9. Role of Apelin/APJ axis in cancer development and progression.
    Javad Masoumi et al, 2020, Adv Med Sci CrossRef
  10. Increased visceral adipose tissue in clear cell renal cell carcinoma with and without peritumoral collateral vessels
    Federico Greco et al, 2020, BJR CrossRef
  11. Relationship between visceral adipose tissue and genetic mutations (VHL and KDM5C) in clear cell renal cell carcinoma
    Federico Greco et al, 2021, Radiol med CrossRef
  12. Study Progression of Apelin/APJ Signaling and Apela in Different Types of Cancer
    Longfei Liu et al, 2021, Front. Oncol. CrossRef
  13. CLINICAL AND THERAPEUTIC VALUE OF ADIPOKINES IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    Ya. M Fylenko, 2020, IMJ CrossRef
  14. microRNAs and bone tumours: role of tiny molecules in the development and progression of chondrosarcoma, of giant cell tumour of bone and of Ewing sarcoma
    Gaia Palmini et al, 2021, Bone CrossRef
  15. The emerging role of the apelinergic system in kidney physiology and disease
    Peter Janssens et al, 2021 CrossRef
  16. Melanoma Progression under Obesity: Focus on Adipokines
    Joanna Olszańska et al, 2021, Cancers CrossRef
  17. Adipogenic Transdifferentiation and Regulatory Factors Promote the Progression and the Immunotherapy Response of Renal Cell Carcinoma: Insights From Integrative Analysis.
    Shuai Wang et al, 2022, Front Oncol CrossRef
  18. Renal Cell Cancer and Obesity
    Anna Gluba-Brzózka et al, 2022, IJMS CrossRef
  19. Updated Functional Roles of NAMPT in Carcinogenesis and Therapeutic Niches
    Tsung-Chieh Lin, 2022, Cancers CrossRef
  20. Adipose Tissue as an Endocrine Organ and a Glance on Local Hormones
    Ebtesam A. Al-Suhaimi, 2022 CrossRef
  21. The Apelin/APLNR system modulates tumor immune response by reshaping the tumor microenvironment
    Yuqin Yang et al, 2022, Gene CrossRef
  22. Roles of apelin/APJ system in cancer: Biomarker, predictor, and emerging therapeutic target
    Jiawei Chen et al, 2022, Journal Cellular Physiology CrossRef
  23. Apelin‐mediated deamidation of HMGA1 promotes tumorigenesis by enhancing SREBP1 activity and lipid synthesis
    Yihan Zhu et al, 2022, Cancer Science CrossRef
  24. Clinicopathological and Body Composition Analysis of VHL and TTN Gene Mutations in Clear Cell Renal Cell Carcinoma: An Exploratory Study
    Federico Greco et al, 2022, Applied Sciences CrossRef
  25. Adipokines as Regulators of Autophagy in Obesity-Linked Cancer
    Alin García-Miranda et al, 2022, Cells CrossRef
  26. Suppression of SREBP-1 Expression by Simvastatin Decreases Visfatin-Induced Chemoresistance to Sunitinib in Human Renal Carcinoma 786-O Cells
    Te-Chuan Chen et al, 2022, Life CrossRef
  27. Potential Value of Visfatin, Omentin-1, Nesfatin-1 and Apelin in Renal Cell Carcinoma (RCC): A Systematic Review and Meta-Analysis.
    Sugania Malar Chinapayan et al, 2022, Diagnostics (Basel) CrossRef
  28. The Role of Adipokines in Health and Disease
    Vicente Javier Clemente-Suárez et al, 2023, Biomedicines CrossRef
  29. Features of adipokine status in hypertensive patients with chronic kidney disease
    Ya.M. Filenko et al, 2022, KIDNEYS CrossRef
  30. Association between leptin level and renal cell carcinoma susceptibility and progression: A meta-analysis.
    Haiquan Zhu et al, 2018, J Cancer Res Ther CrossRef
  31. Impact of Quantitative Computed Tomography-Based Analysis of Abdominal Adipose Tissue in Patients with Lymphoma
    Federico Greco et al, 2023, Hematology Reports CrossRef
  32. Evaluation of Apelin/APJ and Fibronectin Expression in Genitourinary Tumors: An Immunohistochemical Analysis
    Sevinç ŞAHİN et al, 2023 CrossRef
  33. Visceral adiposity in patients with lipomatous hypertrophy of the interatrial septum
    Carlo A. Mallio et al, 2024, Heart Vessels CrossRef
  34. Fat Matters: Exploring Cancer Risk through the Lens of Computed Tomography and Visceral Adiposity
    Federico Greco et al, 2024, JCM CrossRef
  35. Weight-centric prevention of cancer
    Diego Anazco et al, 2024, Obesity Pillars CrossRef
  36. CALCR exacerbates renal cell carcinoma progression via stabilizing CD44
    Haiyang Yan et al, 2024, Aging CrossRef